# FDA Approval of Inhaled Insulin Offers New Option for Teen Diabetes Management
Taisie Siegrist, a teenager with type 1 diabetes, now uses inhaled insulin instead of injections. The FDA approval of this inhalation method has transformed her daily diabetes management and quality of life.
Inhaled insulin delivers medication directly to the lungs, where it absorbs quickly into the bloodstream. This approach eliminates the need for needle injections at mealtimes, reducing pain and the emotional burden many young people experience with traditional insulin therapy. For Taisie, the switch meant less anxiety around eating and socializing.
The product, Afrezza, delivers rapid-acting insulin through a handheld inhaler device. Clinical data shows it works as effectively as injected insulin for managing blood sugar after meals. Teenagers particularly benefit because they gain privacy and discretion. No one at school needs to know they're taking insulin. The device is small and portable, fitting easily into a backpack or pocket.
Dr. Jennifer Seigrist, Taisie's mother, reports that her daughter's compliance improved dramatically after switching to inhaled insulin. Teenagers often struggle with injection adherence, skipping doses to avoid the physical and social discomfort. Removing that barrier encourages better diabetes management overall.
The FDA approval for pediatric use represents progress in making diabetes treatment less intrusive. Doctors note that better adherence leads to better blood sugar control, which reduces long-term complications including heart disease, kidney damage, and vision loss.
Parents considering this option should talk with their child's endocrinologist about whether inhaled insulin fits their family's needs. Insurance coverage varies, and some families may face copay hurdles. The device requires proper inhaler technique, which healthcare providers can teach during office visits.
For families managing type 1 diabetes in teenagers,